Hongcheng Investment
VC Fund
Hongcheng Investment is an investment firm.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Hongcheng Investment invests in
Stages Hongcheng Investment invests in
Countries Hongcheng Investment invests in
Investment Focus
Industry
- Biotechnology 3 (50%)
- Medical 2 (33%)
- Biopharma 2 (33%)
- Health Care 1 (17%)
- Clean Energy 1 (17%)
Stage
- Series B 3 (50%)
- Angel 1 (17%)
- Series A 1 (17%)
- Series C 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
WattDance
|
WattDance is an energy intelligence startup developing advanced physical AI large models for closed loop smart control. The company specializes in building unified networks that optimize source, grid, load, and storage environments. Its technology acts as an intelligent brain to maximize the efficiency of renewable energy assets and modern powergrids. | Angel / Jun 26, 2026 | |
Weikaier Pharmaceutical Technology
|
Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals. | $29.6M / Series C / Jun 02, 2026 | |
Best-Link Bioscience
|
Best-Link Bioscience is a high-tech enterprise engaged in innovative drug research and development, focusing on cutting-edge scientific discovery, advanced therapeutic technologies, and the creation of novel medicines to address unmet clinical needs and improve patient outcomes worldwide. | $36.7M / Series B / Dec 11, 2025 | |
Affinity
|
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs. | $55M / Series B / Dec 02, 2024 | |
Hengyu Biotechnology
|
Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation. | $27.8M / Series B / Mar 11, 2024 | |
Hicicare
|
Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices. | $14M / Series A / Dec 07, 2023 |
Co-Investors
CAS Star
1 deal together
China Growth Capital
1 deal together
China Reform Securities
1 deal together
Chiron Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hongcheng Investment invest in?
Hongcheng Investment invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series B and Angel stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hongcheng Investment last invest?
The most recent investment recorded for Hongcheng Investment closed in Jun 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
